Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fortgeschrittenes und metastasiertes Melanom

Hohe 5-Jahres-Überlebensraten nach Immuncheckpointblockade

  • 10 Accesses

This is a preview of subscription content, log in to check access.

Literatur

  1. 1.

    Larkin J et al. N Engl J Med. 2015;373(1):23-34

  2. 2.

    Hodi FS et al. Lancet Oncol. 2018;19(11):1480-92

  3. 3.

    Robert C et al. N Engl J Med. 2015;372(26):2521-32

  4. 4.

    Schachter J et al. Lancet. 2017;390(10105):1853-62

  5. 5.

    Larkin J et al. N Engl J Med. 2019;381(16):1535-46

  6. 6.

    Robert C et al. Lancet Oncol. 2019;20(9):1239-51

  7. 7.

    Robert C et al. N Engl J Med. 2019;381(7):626-36

Download references

Author information

Correspondence to Prof. Dr. med. Andreas Schalhorn.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Schalhorn, A. Hohe 5-Jahres-Überlebensraten nach Immuncheckpointblockade. InFo Hämatol Onkol 23, 29–30 (2020). https://doi.org/10.1007/s15004-020-7977-8

Download citation